Bright Minds Biosciences Inc. (CSE: DRUG)

Bright Minds Biosciences Balance Sheet

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Cash & Equivalents	6.19	6.75	11.63	19.76	0.8	0.08
Cash & Short-Term Investments	6.19	6.75	11.63	19.76	0.8	0.08
Cash Growth	-23.86%	-41.97%	-41.15%	2370.22%	900.02%	-
Other Receivables	0.02	0.04	0.16	0.11	-	-
Receivables	0.02	0.04	0.16	0.11	-	-
Prepaid Expenses	0.06	0.03	0.16	0.17	0.08	-
Total Current Assets	6.27	6.81	11.95	20.04	0.88	0.08
Property, Plant & Equipment	0.01	0.07	0.14	-	-	-
Other Intangible Assets	-	-	-	0	0	0
Total Assets	6.28	6.88	12.09	20.04	0.88	0.08
Accounts Payable	0.15	0.18	1.25	0.6	0.14	0.04
Accrued Expenses	0.02	0.03	0.16	0.04	0.01	-
Current Portion of Leases	0.01	0.07	0.07	-	-	-
Total Current Liabilities	0.18	0.28	1.47	0.64	0.15	0.04
Long-Term Leases	-	-	0.07	-	-	-
Total Liabilities	0.18	0.28	1.54	0.64	0.15	0.04
Common Stock	35.05	33.91	32.24	27.08	0.98	0.21
Retained Earnings	-33.58	-31.55	-24.17	-9.21	-0.56	-0.08
Comprensive Income & Other	4.63	4.23	2.48	1.53	0.31	-0.08
Shareholders' Equity	6.1	6.6	10.54	19.4	0.73	0.05
Total Liabilities & Equity	6.28	6.88	12.09	20.04	0.88	0.08
Total Debt	0.01	0.07	0.14	-	-	-
Net Cash (Debt)	6.18	6.67	11.49	19.76	0.8	0.08
Net Cash Growth	-23.17%	-41.90%	-41.86%	2370.22%	900.02%	-
Net Cash Per Share	1.49	1.79	4.65	11.01	1.11	0.19
Filing Date Shares Outstanding	4.46	4.46	3.74	2.37	1.27	0.41
Total Common Shares Outstanding	4.46	3.77	3.52	2.37	0.95	0.41
Working Capital	6.09	6.53	10.48	19.4	0.73	0.04
Book Value Per Share	1.37	1.75	3.00	8.20	0.77	0.11
Tangible Book Value	6.1	6.6	10.54	19.4	0.73	0.04
Tangible Book Value Per Share	1.37	1.75	3.00	8.20	0.77	0.10

Source: S&P Capital IQ. Standard template. Financial Sources.